TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy

Abstract Background Transmembrane 9 superfamily member 1 (TM9SF1) is involved in inflammation. Since both inflammatory and autoimmune diseases are linked to immune cells regulation, this study investigated the association between TM9SF1 expression and autoimmune disease activity. As B cell different...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Xiao, Zhenwang Zhao, Fengqiao Zhou, Jinsong Xiong, Zean Yang, Baoxian Gong, Lei Xiang, Mingming Liu, Fengsheng Cao, Hong Xiao, Huabo Chen, Anbing Zhang, Ke Wang
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-024-03729-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850179384092131328
author Juan Xiao
Zhenwang Zhao
Fengqiao Zhou
Jinsong Xiong
Zean Yang
Baoxian Gong
Lei Xiang
Mingming Liu
Fengsheng Cao
Hong Xiao
Huabo Chen
Anbing Zhang
Ke Wang
author_facet Juan Xiao
Zhenwang Zhao
Fengqiao Zhou
Jinsong Xiong
Zean Yang
Baoxian Gong
Lei Xiang
Mingming Liu
Fengsheng Cao
Hong Xiao
Huabo Chen
Anbing Zhang
Ke Wang
author_sort Juan Xiao
collection DOAJ
description Abstract Background Transmembrane 9 superfamily member 1 (TM9SF1) is involved in inflammation. Since both inflammatory and autoimmune diseases are linked to immune cells regulation, this study investigated the association between TM9SF1 expression and autoimmune disease activity. As B cell differentiation and autoantibody production exacerbate autoimmune disease, the signaling pathways involved in these processes were explored. Methods Tm9sf1 −/− mouse rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) models were used to verify the relationship between gene expression and disease severity. Peripheral blood mononuclear cells (PBMCs) from 156 RA and 145 SLE patients were used to explore the relationship between TM9SF1 expression and disease activity. The effectiveness of TM9SF1 as a predictor of disease activity was assessed using multiple logistic regression and receiver operating characteristic (ROC) curves. The signaling pathways regulated by TM9SF1 in B cell maturation and antibody production were conducted by plasma cell induction experiment in vitro. Results The Tm9sf1 −/− RA and SLE model mice produced fewer autoantibodies and showed reduced disease severity relative to wild-type (WT) mice. TM9SF1 levels in PBMCs of patients were higher than those in healthy controls, and were reduced in patients with low disease activity relative to those with active RA and SLE. Furthermore, TM9SF1 levels were positively linked with autoantibody titers and pro-inflammatory cytokine levels in both diseases. ROC analyses indicated TM9SF1 outperformed several important clinical indicators in predicting disease activity (area under the curve (AUC) were 0.858 and 0.876 for RA and SLE, respectively). In vitro experiments demonstrated that Tm9sf1 knockout blocked differentiation of B cells into antibody-producing plasma cells by activating mTOR and inhibiting autophagy, and mTOR inhibitors such as rapamycin could reverse this effect. Conclusions The primary finding was the identification of the molecular mechanism underlying autophagy regulation in B cells, in which Tm9sf1 knockout was found to modulate mTOR-dependent autophagy to block B cell differentiation into antibody-secreting plasma cells. It was also found that TM9SF1 expression level in PBMCs was an accurate indicator of disease activity in patients with RA and SLE, suggesting its clinical potential for monitoring disease activity in these patients.
format Article
id doaj-art-713d48a5ee30401e9ffa2dc77866fe82
institution OA Journals
issn 1741-7015
language English
publishDate 2024-10-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj-art-713d48a5ee30401e9ffa2dc77866fe822025-08-20T02:18:31ZengBMCBMC Medicine1741-70152024-10-0122111910.1186/s12916-024-03729-wTM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagyJuan Xiao0Zhenwang Zhao1Fengqiao Zhou2Jinsong Xiong3Zean Yang4Baoxian Gong5Lei Xiang6Mingming Liu7Fengsheng Cao8Hong Xiao9Huabo Chen10Anbing Zhang11Ke Wang12Institute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceGucheng People’s Hospital, Affiliated Hospital of Hubei University of Arts and ScienceGucheng People’s Hospital, Affiliated Hospital of Hubei University of Arts and ScienceGucheng People’s Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceInstitute of Neuroscience and Brain Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and ScienceAbstract Background Transmembrane 9 superfamily member 1 (TM9SF1) is involved in inflammation. Since both inflammatory and autoimmune diseases are linked to immune cells regulation, this study investigated the association between TM9SF1 expression and autoimmune disease activity. As B cell differentiation and autoantibody production exacerbate autoimmune disease, the signaling pathways involved in these processes were explored. Methods Tm9sf1 −/− mouse rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) models were used to verify the relationship between gene expression and disease severity. Peripheral blood mononuclear cells (PBMCs) from 156 RA and 145 SLE patients were used to explore the relationship between TM9SF1 expression and disease activity. The effectiveness of TM9SF1 as a predictor of disease activity was assessed using multiple logistic regression and receiver operating characteristic (ROC) curves. The signaling pathways regulated by TM9SF1 in B cell maturation and antibody production were conducted by plasma cell induction experiment in vitro. Results The Tm9sf1 −/− RA and SLE model mice produced fewer autoantibodies and showed reduced disease severity relative to wild-type (WT) mice. TM9SF1 levels in PBMCs of patients were higher than those in healthy controls, and were reduced in patients with low disease activity relative to those with active RA and SLE. Furthermore, TM9SF1 levels were positively linked with autoantibody titers and pro-inflammatory cytokine levels in both diseases. ROC analyses indicated TM9SF1 outperformed several important clinical indicators in predicting disease activity (area under the curve (AUC) were 0.858 and 0.876 for RA and SLE, respectively). In vitro experiments demonstrated that Tm9sf1 knockout blocked differentiation of B cells into antibody-producing plasma cells by activating mTOR and inhibiting autophagy, and mTOR inhibitors such as rapamycin could reverse this effect. Conclusions The primary finding was the identification of the molecular mechanism underlying autophagy regulation in B cells, in which Tm9sf1 knockout was found to modulate mTOR-dependent autophagy to block B cell differentiation into antibody-secreting plasma cells. It was also found that TM9SF1 expression level in PBMCs was an accurate indicator of disease activity in patients with RA and SLE, suggesting its clinical potential for monitoring disease activity in these patients.https://doi.org/10.1186/s12916-024-03729-wRheumatoid arthritisSystemic lupus erythematosusTM9SF1AutophagyAntibodyDisease activity
spellingShingle Juan Xiao
Zhenwang Zhao
Fengqiao Zhou
Jinsong Xiong
Zean Yang
Baoxian Gong
Lei Xiang
Mingming Liu
Fengsheng Cao
Hong Xiao
Huabo Chen
Anbing Zhang
Ke Wang
TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
BMC Medicine
Rheumatoid arthritis
Systemic lupus erythematosus
TM9SF1
Autophagy
Antibody
Disease activity
title TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
title_full TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
title_fullStr TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
title_full_unstemmed TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
title_short TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
title_sort tm9sf1 expression correlates with autoimmune disease activity and regulates antibody production through mtor dependent autophagy
topic Rheumatoid arthritis
Systemic lupus erythematosus
TM9SF1
Autophagy
Antibody
Disease activity
url https://doi.org/10.1186/s12916-024-03729-w
work_keys_str_mv AT juanxiao tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT zhenwangzhao tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT fengqiaozhou tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT jinsongxiong tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT zeanyang tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT baoxiangong tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT leixiang tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT mingmingliu tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT fengshengcao tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT hongxiao tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT huabochen tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT anbingzhang tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy
AT kewang tm9sf1expressioncorrelateswithautoimmunediseaseactivityandregulatesantibodyproductionthroughmtordependentautophagy